An infectious diseases expert has called for an urgent reconsideration of a meningitis B vaccination drive for adolescents following a significant outbreak in Kent, particularly centered around Canterbury. Professor Paul Hunter, from the National Institute for Health Research's Emergency Preparedness and Response unit, emphasized that the severity of the outbreak should prompt an immediate review, contingent on whether it represents an isolated incident or a precursor to future occurrences. The outbreak has seen the number of confirmed and suspected cases rise to 34, with five new identifications, and has tragically claimed the lives of two young individuals.

The outbreak is largely believed to have originated at Club Chemistry in Canterbury. Concerns mounted that students returning home for the Easter holidays could inadvertently spread the disease, potentially leading to sporadic household cases beyond the initial epicentre. Public health officials noted that secondary cases, involving individuals who contracted the disease from someone infected at Club Chemistry rather than directly at the venue, should be manageable, and they believed the outbreak was nearing its peak.

In response, hundreds of students at the University of Kent queued to receive vaccinations. More immediate protection was provided by antibiotics, with health chiefs reporting over 12,000 doses delivered. Professor Hunter, also from the University of East Anglia's Norwich School of Medicine, underscored the critical importance of swift contact identification, antibiotic provision, and public health advice as soon as an outbreak is suspected.

Tragically, 18-year-old Juliette Kenny, a sixth-form student, and an unnamed 21-year-old University of Kent student have died. Juliette's father, Michael Kenny, expressed profound grief and urged for enhanced protections and improved access to the MenB vaccination for young people. The MenB jab was incorporated into the NHS vaccination schedule for babies in 2015, leaving many older adolescents unprotected unless they received private vaccinations. Despite the demand, the UK Health Security Agency confirmed no supply issues with vaccines or antibiotics, ensuring sufficient stocks at the university, local hospitals, and with ambulance services.

The vaccination program initially rolled out for University of Kent students was subsequently expanded to include schoolchildren aged 15 and 16 in Kent, specifically Year 11 and sixth-form pupils at schools with known or suspected meningitis cases. Health Secretary Wes Streeting confirmed this expansion, aiming to provide long-term protection. As of a recent update, there were 20 confirmed cases, with three under further investigation, a reduction from nine investigations previously. All diagnosed individuals required hospital admission, with nine receiving intensive care, and four still remaining there.

A new mutation of group B meningococci bacteria has been identified as the driving force behind the outbreak. However, early analyses by Professor Robin May, chief scientific officer at UKHSA, offer reassurance that existing vaccinations and antibiotic treatments remain effective against this particular strain. Professor Paul Hunter further noted that while the strain has existed for about five years, it has undergone several mutations since 2020, though their contribution to the